Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.

Xinyu Zhao,Min Li,Hao Wang,Xiaoqian Xu,Xiaoning Wu,Yameng Sun, Canjian Ning,Bingqiong Wang,Shuyan Chen,Hong You,Jidong Jia,Yuanyuan Kong

Journal of clinical and translational hepatology（2022）

引用 4|浏览13

暂无评分

摘要

The implementation of the NCDP policy significantly increased the utilization of first-line NAs for CHB patients at a lower expenditure. The findings provided evidence for optimizing antiviral therapy strategy and allocating medical resources in China.

查看译文

关键词

Antiviral therapy,Chronic hepatitis B,Drug expenditures,Drug utilization,National centralized drug procurement

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要